EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Relative Bioavailability of Lutein and Zeaxanthin in the Presence of Omega-3 Supplements and Their Effect on Oxidative Stress Levels in Humans: A Pilot Study

Kingsley Arua Kalu iD, Charles McMonnies iD, Sophia Lin iD, Jayashree Arcot iD

Nutrients · 12.06.2026 · 18 (12) · 1914

DOI: 10.3390/nu18121914 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 12.06.2026. Verfasst von Kingsley Arua Kalu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Food and Health, School of Chemical Engineering, University of New South Wales, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Dietary Supplements, Fatty Acids, Omega-3, Lutein, Oxidative Stress. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lutein+Zeaxanthin (L+Z) are the major constituents of macular pigments of the retina. There is a lack of information on the bioavailability of the two compounds in the presence and absence of omega-3 fatty acids in L+Z supplements which are commonly prescribed to treat macular degeneration. Despite growing interest in L+Z supplementation, there remains a limited understanding of their short-term bioavailability dynamics and the potential added value of omega-3 co-supplementation. This pilot study reports on the bioavailability of serum responses to L+Z supplements in the presence of omega-3 fatty acids and evaluates time-resolved analytical approaches using Area Under the Curve. Subjects/Methods: A total of 10 men and six women with an average age of 31.38 ± 1.27 years participated in this randomised, non-blinded, controlled study for a total of 19 days (7-day wash-out period plus 12-day intervention period). The control group (n = 9) consumed the L+Z supplement (12 mg/d) only, while the intervention group (n = 7) consumed the L+Z supplement along with 900 mg/d of an omega-3 supplement (540 mg EPA + DHA 360 mg). Each group adhered to a comprehensive low-carotenoid and omega-3 diet list (LCOD) for the 7-day wash-out period and the 12-day intervention period. The participants reported the foods they consumed daily in their diet logbooks, online logs, and the ASA 24 diet assessment log over the study period. The body composition of each subject in the two groups was assessed before and after the study using a SECA body composition analyser, and the relative serum L+Z response in both groups was determined using Area Under the Curve (AUC and incremental AUC) by trapezoidal approximation.

Results

The mean ± SEM baseline serum lutein+zeaxanthin (L+Z) concentrations measured at the end of the wash-out period (Day 7) were 2.23 ± 0.65 µg/mL in the control group and 1.20 ± 0.53 µg/mL in the intervention group. Following wash-out, serum L+Z concentrations increased in both groups, reaching 2.81 ± 0.90 µg/mL (control) and 2.63 ± 1.21 µg/mL (intervention) at Day 13, and 2.98 ± 0.69 µg/mL (control) and 3.02 µg/mL (intervention) at Day 19. Total exposure assessed by AUC7–13 and AUC13–19 did not differ significantly between the groups (p > 0.05). Incremental exposure analyses identified the post-wash-out period as the primary biologically responsive window, with higher mean incremental L+Z bioavailability in the intervention group (4.36 µg/day/mL) compared with the control group (3.00 µg/day/mL), although this difference was not statistically significant (p > 0.05). No significant effect of omega-3 co-supplementation on oxidative stress biomarkers was observed (p > 0.05).

Conclusion

Omega-3 co-supplementation did not demonstrate a consistent additional benefit on L+Z bioavailability or oxidative stress markers. Day-resolved analyses using iAUC revealed temporal patterns not captured by conventional AUC measures. These exploratory findings should be interpreted with caution and confirmed in larger, longer-term studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsFatty Acids, Omega-3LuteinOxidative StressZeaxanthinsAdultFemaleHumansMaleBiological AvailabilityPilot Projects

Stichwörter der Autor:innen

AUCbioavailabilitydietary supplementationiAUCluteinmalondialdehydenutrient kineticsomega-3 fatty acidsoxidative stresszeaxanthin

Substanzen

Fatty Acids, Omega-3LuteinZeaxanthins

Autor:innen und Institutionen

  • Food and Health, School of Chemical Engineering, University of New South Wales, Sydney, NSW 2052, Australia.
  • School of Optometry and Vision Science, University of New South Wales, Sydney, NSW 2052, Australia.
  • School of Health Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

ORCID-Profile: Kingsley Arua Kalu, Charles McMonnies, Sophia Lin, Jayashree Arcot

Zitieren

APA

Kalu, K. A., McMonnies, C., Lin, S., & Arcot, J. (2026). The Relative Bioavailability of Lutein and Zeaxanthin in the Presence of Omega-3 Supplements and Their Effect on Oxidative Stress Levels in Humans: A Pilot Study. Nutrients, 18(12), 1914. https://doi.org/10.3390/nu18121914

Vancouver

Kalu KA, McMonnies C, Lin S, Arcot J. The Relative Bioavailability of Lutein and Zeaxanthin in the Presence of Omega-3 Supplements and Their Effect on Oxidative Stress Levels in Humans: A Pilot Study. Nutrients. 2026;18(12):1914. doi:10.3390/nu18121914

BibTeX
@article{Kalu2026,
  author = {Kalu, Kingsley Arua and McMonnies, Charles and Lin, Sophia and Arcot, Jayashree},
  title = {The Relative Bioavailability of Lutein and Zeaxanthin in the Presence of Omega-3 Supplements and Their Effect on Oxidative Stress Levels in Humans: A Pilot Study},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1914},
  doi = {10.3390/nu18121914}
}
Kostenlos starten →